Clinical Trial

A Phase Ⅲ Clinical Study of Combined Cisplatin Versus Placebo Combined With Intracavitary Cisplatin Injection in the Treatment of Malignant Pleural Effusions

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
Malignant Pleural Effusion or Ascites is a common complication of malignant tumor, The objective of this study is to compare the efficacy of Endostar/cisplatin with placebo/cisplatin in patients with malignant pleural effusion or ascites.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2021-05-31.
Status change: Not Yet Recruiting → Active, Not Recruiting 2025-12-29
Trial Details
NCT Number NCT04914598
Lead Sponsor Jiangsu Simcere Pharmaceutical Co., Ltd.
Conditions Malignant Pleural Effusion
Enrollment 290 participants
Start Date 2021-07-28
Primary Completion 2025-02-10 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2026-01-02